Device Trial Radar · NCT07791381
Study of an Implantable Collamer Lens (ICL)
Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Staar Surgical CompanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 27, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, open-labeled, single-site study of an implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.
Conditions
- Myopia
- Astigmatism
Interventions
Implantable collamer lens (ICL)Device
ICL with aspheric optic
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative and Persistent Adverse EventsTime frame: 3 Months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.